Recent developments in genetic technologies have accelerated us towards a new era of medicine. Personalised medicine is quickly moving from the realm of science fiction to everyday healthcare, whilst scientific ability to alter human genetics is growing every year, raising a range of ethical issues. How do we make sure that these developments are equally shared across society? What measures can be put in place to prevent patients being unfairly penalised for having certain genes? Hear from our expert panel as we discuss the medical and ethical implications of these new genetic technologies. The panel includes: Dr Robin Lovell-Badge CBE FRS, Stem Cell Geneticist, The Francis Crick Institute Dr Sarah Chan, Public Health Ethicist, The University of Edinburgh Dr Andrea Nemeth, Associate Professor, Nuffield Department of Clinical Neurosciences, University of Oxford For more upcoming events, please visit royalsociety.org/science-events-and-lectures/

Be the first to comment